Asian Pan-cancer Assay presented at FCS 2021
- Cedric Ng
- Nov 6, 2021
- 1 min read
Recently, our lab developed test for molecular profiling of prevalent Asian cancers was presented at the Frontiers in Cancer Science 2021 conference!
This is a commercially available cancer tissue diagnostic platform created in collaboration by SingHealth, Agency for Science, Technology and Research (A*STAR)’s Diagnostics Development (DxD) Hub, Singapore General Hospital (SGH), National Cancer Centre Singapore (NCCS) and Lucence.
Check out our poster below.
Mr Cedric Ng
Chief Technology Officer, Cancer Discovery Hub
National Cancer Centre Singapore
Commentaires